cx	cy	x	y	score	nptumor	nphit	tumor	name	status	top
748.3950456308112	-6.78507988850177	753.0650642963608	0.45935587922213	0.6133	423	9	COAD	LRP6	Approved in other pathologies	AT9283 | ENZASTAURIN | VANTICTUMAB
769.5973472076208	-1.60658840893365	770.6945067436077	1.19354631090437	0.6328	543	13	LUAD	FLT4	Approved in same tumor type	SORAFENIB | REGORAFENIB | PAZOPANIB
749.2395370942453	-16.4836217105901	759.9882084124667	0.0433636091115659	0.6198	264	16	SKCM	EGF	Approved in same tumor type	AFATINIB | NILOTINIB | PONATINIB
900.4170807958515	-0.563797576901237	898.603552007426	0.884993065510116	0.7774	512	12	UCEC	SOS1	Approved in same tumor type	BOSUTINIB | PONATINIB | REGORAFENIB
985.2840256366387	-0.133738580943771	987.5067231038706	0.321917294219702	0.8736	512	13	UCEC	TSC2	Approved in same tumor type	EVEROLIMUS | TEMSIROLIMUS | MIDOSTAURIN
921.675757719514	10.3379226280113	933.9105284608594	-1.25565311550304	0.8091	512	26	UCEC	MTOR	Approved in same tumor type	EVEROLIMUS | TEMSIROLIMUS | PAZOPANIB
1061.1134111034808	68.3782515814986	1025.0913998723383	21.1818026196338	0.9339	343	215	HNSC	TP53	Approved in same tumor type	PACLITAXEL | DOCETAXEL | ABT-199
831.6324292018961	-1.62910954477763	816.9313357959879	0.00200416251300339	0.6869	292	16	STAD	TRIO	Clinical trials in cancer	141400-58-0 | GOSSYPOL | FEDRATINIB
752.2405034712069	12.5717666657065	744.7071184928677	2.32112321751458	0.6044	389	18	LUSC	FN1	Approved in cancer	BOSUTINIB | DASATINIB | PONATINIB
912.958301521514	8.4227144319708	907.4710505129901	-5.44641099301055	0.7931	389	27	LUSC	CDKN2A	Approved in cancer	BOSUTINIB | ARSENIC TRIOXIDE | PALBOCICLIB
799.1148159185589	8.33788203698316	792.430216181774	0.23262427086047	0.6566	512	12	UCEC	PDGFRA	Approved in same tumor type	SORAFENIB | REGORAFENIB | SUNITINIB
827.0020571509572	0.372204919569356	828.00007627469	0.000524783141145235	0.6974	512	15	UCEC	ATP1A2	Approved in other pathologies and in clinical trials in cancer	DIGOXIN
775.5964701426152	9.30412904761192	783.93599593609	2.81915780124655	0.6495	153	6	BLCA	PDGFRA	Approved in same tumor type	PAZOPANIB | COPANLISIB | SORAFENIB
775.7928247478549	-4.85977025239345	781.5688286756041	1.45950760048254	0.6445	512	11	UCEC	MAP4K1	Approved in same tumor type	COBIMETINIB | TRAMETINIB | 391210-10-9
982.2966440219432	-0.119661823830427	980.99998420486	-0.000335396013269929	0.8681	292	6	STAD	NGF	Approved in cancer	NILOTINIB | DASATINIB | BOSUTINIB
792.2944540574701	22.269448009954	790.9999808537431	0.000116410420503144	0.6567	57	3	PAAD	STK39	Clinical trials in cancer	2797-51-5 | YM155
1030.5196182810319	5.57746859036837	1028.9996380243867	0.000161094143777518	0.921	292	9	STAD	CTNNB1	Approved in same tumor type	ARSENIC TRIOXIDE | VANDETANIB | BEVACIZUMAB
738.609923794057	8.52569230556094	745.1618555301519	1.45791489846488	0.6044	292	14	STAD	FN1	Approved in cancer	BOSUTINIB | PONATINIB | MIDOSTAURIN
914.923456707468	32.1203012239346	923.9733057387804	0.153294199211814	0.8089	153	50	BLCA	TP53	Approved in same tumor type	DOCETAXEL | PACLITAXEL | ABT-199
954.6750164290764	-3.88380930812093	957.0000678434742	0.000601303953772003	0.8414	134	3	CESC	PTEN	Approved in cancer	COPANLISIB | DASATINIB | BOSUTINIB
1000.9745476075775	3.67323675199637	998.9995249824991	0.000507708797499618	0.888	169	5	READ	NRAS	Approved in same tumor type	SORAFENIB | COPANLISIB | ARSENIC TRIOXIDE
900.6428292371854	5.35847207806984	892.0006889045156	-0.000270321691459685	0.7689	423	10	COAD	KCNQ3	Approved in other pathologies and in clinical trials in cancer	CELECOXIB | RETIGABINE | GUANIDINE HYDROCHLORIDE
785.5952198738215	-17.6701601815504	777.3282161356863	-0.0981159274592756	0.6474	264	14	SKCM	BRD4	Approved in cancer	DOCETAXEL | BI 2536 | CPI-0610
813.6001342933855	-10.1159513929918	781.7932628166741	8.07994316479972	0.655	264	27	SKCM	FLT3	Approved in same tumor type	SUNITINIB | SORAFENIB | MIDOSTAURIN
792.5773370058824	12.6082984829162	794.5233899929358	-12.3090568648063	0.654	264	11	SKCM	BCR	Approved in same tumor type	BOSUTINIB | COPANLISIB | DASATINIB
768.2188919946531	-4.66220561674371	775.0743754689455	-0.00138336833060748	0.639	343	11	HNSC	PTCH1	Approved in cancer	VISMODEGIB | LY2940680 | BMS-833923
883.755365567961	-7.03734248800433	899.300040617811	0.923692716261485	0.7787	264	14	SKCM	IDH1	Approved in same tumor type	DASATINIB | BEVACIZUMAB | ABT-199
1066.3941353503026	4.70792282836368	1063.9997721769437	-0.000295349318321314	0.9603	512	20	UCEC	RB1	Approved in same tumor type	DASATINIB | PONATINIB | BOSUTINIB
784.6000337085247	-12.3030940128143	784.5494400490113	-13.2377472710755	0.6586	264	10	SKCM	FGFR1	Approved in same tumor type	SORAFENIB | REGORAFENIB | SORAFENIB TOSYLATE
941.1220790473506	-0.405960289240852	940.0000289143385	-0.000528492186731455	0.8225	934	19	BRCA	AKT1	Approved in same tumor type	ARSENIC TRIOXIDE | PACLITAXEL | EVEROLIMUS
784.451125463305	10.8687502656191	773.4560174508362	-7.75188942284649	0.6379	512	21	UCEC	CACNA1D	Approved in other pathologies and in clinical trials in cancer	VERAPAMIL | CELECOXIB | VERAPAMIL HYDROCHLORIDE
1087.2826888204959	-5.9115128379496	1075.9998781601403	0.000669267020612097	0.9737	169	38	READ	KRAS	Approved in same tumor type	SORAFENIB | COPANLISIB | ARSENIC TRIOXIDE
807.8031213473805	-21.9546578883131	769.8621482705001	27.8976400062897	0.6566	264	31	SKCM	ABCB1	Approved in same tumor type	IMATINIB | TAMOXIFEN | PACLITAXEL
767.2736424557937	3.71852605704672	765.5063778262087	0.758265526279729	0.6284	292	7	STAD	TGFBR2	Experimental	3-(4-FLUOROPHENYL)-2-(6-METHYLPYRIDIN-2-YL)-5,6-DIHYDRO-4H-PYRROLO[1,2-B]PYRAZOLE | 396129-53-6 | 1132610-45-7
811.9744099017136	3.56720329673476	797.3526671573221	-2.10242849113456	0.6709	264	7	SKCM	STAT6	Approved in cancer	PEMETREXED | INDOMETHACIN | INDISULAM
770.0882548816274	1.81715894352863	776.2570584087546	-4.28823845841089	0.6339	512	17	UCEC	GNAS	Approved in cancer	PONATINIB | DASATINIB | BOSUTINIB
742.8833621685054	7.47803351442508	746.9999727019161	3.11193836068924e-05	0.6075	117	3	KIRP	ITGAL	Approved in cancer	MIDOSTAURIN | TAMOXIFEN | RUXOLITINIB
738.1245746612192	0.671482808295309	741.6671112479347	-0.121558573499442	0.6015	264	6	SKCM	MAP3K2	Approved in other pathologies	TALMAPIMOD | LY2228820 | OZAGREL
781.7497302868903	2.72066787976007	784.5509181943231	2.5067902661558	0.6493	512	16	UCEC	MAP3K4	Clinical trials in cancer	ABT-751 | YK-4-279 | RITA
754.2528492047052	-20.9005981286141	756.3920747232852	-0.76197921048265	0.6164	512	26	UCEC	TRRAP	Approved in other pathologies	LEXIBULIN | P-0850 | MANUMYCIN
1039.6614873631038	-0.44744754647644	1045.1133301374236	-4.90567501040948	0.9368	599	32	GBM	NF1	Approved in same tumor type	REGORAFENIB | BOSUTINIB | SORAFENIB TOSYLATE
793.0549052673606	-0.675738634029898	795.4097612044014	-1.44067349322631	0.6623	292	7	STAD	SMAD2	Approved in cancer	NILOTINIB | DASATINIB | BOSUTINIB
768.75614955809	-18.2237577645078	771.9256884407461	0.00114912984099647	0.6358	343	7	HNSC	PDGFRB	Approved in same tumor type	SORAFENIB | DASATINIB | REGORAFENIB
784.6893397574838	7.14556637590391	783.0112360076989	-0.674686044199461	0.6432	512	11	UCEC	RET	Approved in same tumor type	SUNITINIB | VANDETANIB | CABOZANTINIB
785.4821669686128	-5.4818188767141	792.0459028224225	-0.00816159496122282	0.6582	389	13	LUSC	KDR	Approved in same tumor type	COPANLISIB | MIDOSTAURIN | PONATINIB
774.9466013174165	-2.38607078835204	769.3050059969584	-1.19398638396251	0.6336	543	12	LUAD	CACNA1D	Approved in other pathologies and in clinical trials in cancer	VERAPAMIL | CELECOXIB | VERAPAMIL HYDROCHLORIDE
973.7267351096051	17.9208866058858	956.999836800125	0.000541687498184729	0.8414	599	90	GBM	PTEN	Approved in cancer	DASATINIB | BOSUTINIB | COPANLISIB
1064.445721555088	9.14512510010593	1063.999321907808	-8.43376645889293e-05	0.9603	599	25	GBM	RB1	Approved in same tumor type	BOSUTINIB | DASATINIB | REGORAFENIB
935.368724175838	-71.1675775089157	956.913777637089	-32.7698073237939	0.831	264	132	SKCM	BRAF	Approved in same tumor type	TRAMETINIB | SORAFENIB | COBIMETINIB
817.1080705692294	-3.66699122693697	814.9999465877154	-0.000286969374883483	0.6834	343	7	HNSC	SOS1	Approved in same tumor type	BOSUTINIB | TRAMETINIB | SORAFENIB
901.8858768473826	-3.17673934806521	903.7004859936935	-0.924280799162261	0.7805	264	7	SKCM	PIK3CA	Approved in same tumor type	COPANLISIB | PACLITAXEL | TRAMETINIB
890.9285936059644	-6.29844511739796	891.7411514545001	-0.927142818045013	0.7689	512	17	UCEC	KCNQ3	Approved in other pathologies and in clinical trials in cancer	CELECOXIB | RETIGABINE | GUANIDINE HYDROCHLORIDE
767.3940529497498	-0.0179380657077104	777.5507959633312	0.00160463201336825	0.6415	423	9	COAD	PRKD1	Approved in other pathologies and in clinical trials in cancer	LOVASTATIN | LIFITEGRAST | EFALIZUMAB
764.7231542795323	1.63214114197592	765.9222149276144	3.12393800837344	0.6308	512	16	UCEC	PLCG2	Approved in same tumor type	SORAFENIB | REGORAFENIB | ARSENIC TRIOXIDE
965.652237950946	-9.30565011936366	939.2871104014134	13.8799798872487	0.8244	264	34	SKCM	CDKN2A	Approved in cancer	ARSENIC TRIOXIDE | BOSUTINIB | PALBOCICLIB
759.5353863826681	-18.9966843087041	763.4651562185038	-5.61073683510676	0.624	512	22	UCEC	RASA1	Approved in same tumor type	TRAMETINIB | COBIMETINIB | SORAFENIB
776.4471178140441	5.20811939602604	779.72614611927	1.12556106206443	0.6445	292	8	STAD	ACSL3	Approved in other pathologies	ICOSAPENT
904.7051430588784	9.18823642842159	901.5705287444031	0.430141998417298	0.7805	389	27	LUSC	PIK3CA	Approved in same tumor type	COPANLISIB | SORAFENIB | PONATINIB
744.6866435602307	-11.0504550742769	751.1627532599794	5.21190084169803	0.6214	264	11	SKCM	PPARG	Approved in cancer	BEXAROTENE | TRETINOIN | SULFASALAZINE
754.3420600093032	-0.327624545454825	758.6240954646595	0.525390264987891	0.6215	292	6	STAD	TLR9	Approved in cancer	IMIQUIMOD | HYDROXYCHLOROQUINE | RESIQUIMOD
785.4288528319499	3.92250249344434	791.9620307228984	-2.61308446468047	0.6566	292	10	STAD	ABCB1	Approved in same tumor type	CARBOPLATIN | DAUNORUBICIN | HYDROXYUREA
778.7908821587982	3.58892064090603	781.8900077428643	-0.769703187740333	0.645	292	6	STAD	MAP3K4	Clinical trials in cancer	RITA | NSC-87877 | CHAETOCIN
776.6607159018467	2.3811781732042	774.3695722510414	-0.421060717098499	0.6391	292	6	STAD	CSNK1E	Approved in cancer	VISMODEGIB
1007.745715229898	-53.2995330168938	1043.0211981546126	0.172877911301612	0.9339	222	88	LGG	TP53	Approved in same tumor type	PACLITAXEL | ABT-199 | DOCETAXEL
797.5500848424742	3.45307263479535	789.2975292844566	3.22867083975234	0.6546	512	25	UCEC	FBN2	Approved in cancer	32703-82-5 | ZEBULARINE | LEUCASCANDROLIDE A
835.5190877427076	1.3199080114473	834.2882624533997	0.0137875791542683	0.704	264	7	SKCM	TERT	Approved in cancer	ARSENIC TRIOXIDE | HOMOHARRINGTONINE | RALOXIFENE
852.7890502922688	22.3833746273307	934.2956060457973	0.0414987770420794	0.8089	169	45	READ	TP53	Approved in same tumor type	PACLITAXEL | ABT-199 | BORTEZOMIB
1066.8248947038383	22.6945979909351	1049.1578389141443	0.00524832212835236	0.9515	57	8	PAAD	SMAD4	Approved in cancer	BOSUTINIB | ARSENIC TRIOXIDE | DASATINIB
784.4985994076155	15.8014554207254	801.9158295562108	8.89941270269583	0.6597	264	11	SKCM	IKBKE	Approved in cancer	SMR000449312 | GALIXIMAB | TARENFLURBIL
780.4359119447968	-6.4056236060249	791.9553106767298	0.880034900070314	0.6539	292	7	STAD	FGFR1	Approved in same tumor type	SORAFENIB | REGORAFENIB | DABRAFENIB
782.2938442955109	-4.22804573169495	777.0405131703819	-0.385472000440132	0.64	292	7	STAD	CNR1	Experimental	GUANOSINE 5&#39;-DIPHOSPHATE
1124.189574184235	8.23696727678418	1014.999576387338	-0.00127946566385617	0.9059	502	218	KIRC	VHL	Approved in same tumor type	VANDETANIB | PONATINIB | AXITINIB
745.7930263579161	5.09529833646477	761.9926549613741	-0.396557628736218	0.624	292	11	STAD	RASA1	Approved in same tumor type	SORAFENIB | REGORAFENIB | BOSUTINIB
830.3630224792436	10.925197369588	824.493039350184	7.99657854802535	0.6788	264	41	SKCM	ERBB4	Approved in same tumor type	COPANLISIB | LAPATINIB | AFATINIB
1072.2095706981293	-11.0131491357891	1075.9999220348384	0.000278403354741386	0.9737	202	8	LAML	KRAS	Approved in same tumor type	SORAFENIB | REGORAFENIB | COPANLISIB
822.5208616246595	3.26366576402714	822.0001795863334	0.00023840664493946	0.6906	512	14	UCEC	APP	Clinical trials	NADH | AEBSF
993.3992384629446	0.122799958655179	1003.8991228758833	0.928381478991469	0.8966	264	29	SKCM	IL7R	Approved in cancer	RUXOLITINIB
895.6367505282822	-6.04060384826121	890.8422965130214	-0.00136854066340675	0.769	292	13	STAD	COL1A2	Approved in other pathologies	COLLAGENASE CLOSTRIDIUM HISTOLYTICUM | COLLAGENASE | OCRIPLASMIN
908.6137194530081	-7.31335012341748	905.0000237502145	-0.000295318980079173	0.7835	423	32	COAD	PIK3CA	Approved in same tumor type	COPANLISIB | PACLITAXEL | RIBOCICLIB
767.541327056692	9.59740038592196	773.5211740048542	5.64593182865565	0.639	512	19	UCEC	PTCH1	Approved in cancer	LY2940680 | BMS-833923 | FLUOCINONIDE
911.5276806518358	-16.5420352331827	916.8249412168924	-2.74419049368771	0.8001	292	25	STAD	PIK3CA	Approved in same tumor type	COPANLISIB | EVEROLIMUS | TRASTUZUMAB
892.8335146883668	-9.32773083660561	895.157364122595	0.00139287026468082	0.7708	292	8	STAD	ADCY1	Clinical trials in cancer	DINACICLIB | TALMAPIMOD | FLAVOPIRIDOL
1034.341228042145	-0.77069955415601	1038.1731733801887	-5.95597191746447	0.9318	423	15	COAD	NRAS	Approved in same tumor type	SORAFENIB | COPANLISIB | TRAMETINIB
806.7214193449471	5.74850378142278	806.8121131035668	-0.297358515971609	0.673	512	12	UCEC	USP6	Experimental	SGC0946 | AVRAINVILLAMIDE | BMS-536924
1001.0739117521175	-2.55133547310754	1007.0010299762712	0.000197338855741691	0.8968	423	11	COAD	ESR1	Approved in same tumor type	COPANLISIB | TAMOXIFEN | FULVESTRANT
777.4847109529153	-1.59657588166752	773.7909854868776	2.65084826297925	0.6403	264	6	SKCM	MAPK9	Approved in other pathologies	HEPARIN
751.5919497564596	22.7321179064396	759.0141416449407	1.50574088658487	0.6199	389	18	LUSC	TPR	Approved in cancer	PEMETREXED | FEDRATINIB | 141400-58-0
778.5927751961639	-4.19462120061013	778.8072039181394	1.99203454717917	0.6443	512	13	UCEC	JAK2	Approved in same tumor type	RUXOLITINIB | PACLITAXEL | RUXOLITINIB PHOSPHATE
771.4574059740248	8.60154379933448	769.8162901903196	7.85690101976252	0.6389	264	8	SKCM	HIPK2	Clinical trials in cancer	ABT-751 | DMXAA | LY2183240
956.006959903661	-7.10889163366664	956.9998481798152	0.000428101259615232	0.8414	389	14	LUSC	PTEN	Approved in cancer	COPANLISIB | BOSUTINIB | DASATINIB
927.7308793311429	13.368114359128	940.99959860043	0.00045185903491074	0.8231	543	28	LUAD	EGFR	Approved in same tumor type	SORAFENIB | BOSUTINIB | DABRAFENIB
797.266723749143	-29.0871123710866	801.7457597467445	-7.88271775261819	0.6687	264	25	SKCM	USP6	Experimental	TRIACSIN C | SGC0946 | AVRAINVILLAMIDE
923.0927600654375	-6.69369336326758	927.7562863305175	-2.5418211704141	0.8091	423	20	COAD	BRAF	Approved in same tumor type	TRAMETINIB | SORAFENIB | COBIMETINIB
763.4816586561237	7.71543400146089	765.219069802616	-1.71878048259578	0.6275	153	4	BLCA	MAPK9	Approved in other pathologies	HEPARIN
1017.8787946016396	6.49707795578973	1013.999868897108	0.000238092380527632	0.9039	117	3	KIRP	PTEN	Approved in cancer	DASATINIB | BOSUTINIB | PONATINIB
788.0986683083663	-10.744524364141	780.999875877947	-0.00041531773058523	0.6457	423	11	COAD	TIAM1	Clinical trials	QUERCETIN | GUANOSINE 5&#39;-DIPHOSPHATE | BISINDOLYLMALEIMIDE I
766.8786873468727	14.5872076178757	761.8157485207072	5.37120073018514	0.6226	512	24	UCEC	TPR	Approved in cancer	PEMETREXED | SERDEMETAN | ZEBULARINE
1034.902713610298	2.90234545912097	1033.8013119261484	-1.14193096981126	0.9278	264	7	SKCM	KIT	Approved in same tumor type	TRAMETINIB | SUNITINIB | SORAFENIB
961.1881868009962	-0.434171564093532	958.9999470780184	0.000337902990395378	0.8438	543	20	LUAD	STK11	Approved in same tumor type	ARSENIC TRIOXIDE | PALBOCICLIB | RIBOCICLIB
807.3640052148736	-0.722534918633784	808.2244838028606	-0.0548013243192145	0.677	423	9	COAD	COL1A1	Approved in cancer	COPANLISIB | PONATINIB | DASATINIB
959.8427079090898	3.67577565577361	952.7465365978801	-2.91090124537209	0.8414	222	8	LGG	PTEN	Approved in cancer	BOSUTINIB | COPANLISIB | DASATINIB
755.6657714355731	-2.77180065623438	755.0421642828886	6.51632326681192	0.6176	264	7	SKCM	ERBB2	Approved in same tumor type	COPANLISIB | TEMSIROLIMUS | LAPATINIB
738.0634570044949	-1.90804102102848	741.499835766613	-0.0888793081645645	0.6018	389	8	LUSC	IL7R	Approved in cancer	RUXOLITINIB
954.3579967705981	-0.685343885844873	947.9992070859261	-0.000744040286008385	0.831	543	17	LUAD	BRAF	Approved in same tumor type	SORAFENIB | REGORAFENIB | ARSENIC TRIOXIDE
796.0951096632602	-7.71173761554624	795.1008604645632	-0.124752339414272	0.6604	512	11	UCEC	IL6ST	Clinical trials in cancer	INDISULAM | SA237 | RITA
922.3141148731044	5.04581977052996	929.98942784919	1.12460792672982	0.8125	264	10	SKCM	GPC3	Approved in cancer	ARSENIC TRIOXIDE | XL-228 | VANTICTUMAB
749.9938352550342	4.87855081243461	749.9350288204703	-0.460538527805056	0.6121	423	14	COAD	TRRAP	Approved in other pathologies	LEXIBULIN | MK-1775 | CURCUMIN
888.6235013369997	-10.2769959044238	884.9998541632112	-0.000164907183943797	0.7615	292	13	STAD	GNAS	Approved in cancer	DASATINIB | BOSUTINIB | PONATINIB
737.4557659151825	-9.43106010800199	747.8465033865339	-2.37910530805993	0.6077	264	8	SKCM	AKT2	Approved in cancer	EVEROLIMUS | TRASTUZUMAB | GDC-0068
798.7118533989367	-1.42705154189906	794.3364227260731	3.18739417636061	0.6587	512	18	UCEC	ROS1	Approved in same tumor type	CRIZOTINIB | CABOZANTINIB | CERITINIB
803.4491123772729	10.9043495763588	786.2505907578529	2.11590487673993	0.6566	543	20	LUAD	ABCB1	Approved in same tumor type	IMATINIB | PACLITAXEL | GEFITINIB
1060.054674414106	-3.11223860168019	1063.999747036914	-1.08909257505729e-05	0.9603	543	13	LUAD	RB1	Approved in same tumor type	BOSUTINIB | AXITINIB | REGORAFENIB
746.7224904794748	-4.69161337988564	743.98040094065	2.02411996819365	0.6038	512	12	UCEC	MET	Approved in same tumor type	CABOZANTINIB | COPANLISIB | PACLITAXEL
809.9242168609001	6.35321471922816	811.9998770824448	-0.000518357357350396	0.6804	512	16	UCEC	ERBB4	Approved in same tumor type	COPANLISIB | ADO-TRASTUZUMAB EMTANSINE | ACALABRUTINIB
823.4390944010083	-0.0922818937528405	822.0683213530848	-0.000761093416713265	0.6895	292	9	STAD	EGFR	Approved in same tumor type	SORAFENIB | BOSUTINIB | DABRAFENIB
738.1882617454279	3.85266354780913	744.841564357891	-0.331511430187675	0.6053	264	8	SKCM	TGFBR2	Experimental	3-(4-FLUOROPHENYL)-2-(6-METHYLPYRIDIN-2-YL)-5,6-DIHYDRO-4H-PYRROLO[1,2-B]PYRAZOLE | 396129-53-6 | 1132610-45-7
773.298393146363	-9.77507006234995	761.0153978676171	-1.40440412114185	0.6231	423	9	COAD	MAP2K4	Approved in same tumor type	ARSENIC TRIOXIDE | VINBLASTINE | CC-401
1044.4915672432992	-5.06290727091258	1044.0780929542798	2.55581043675193	0.9372	292	17	STAD	KRAS	Approved in same tumor type	SORAFENIB | REGORAFENIB | COPANLISIB
807.2530599418719	9.09861429543901	803.5865442157315	0.772726897084112	0.6701	512	17	UCEC	KIT	Approved in same tumor type	SUNITINIB | SORAFENIB | DASATINIB
1037.0228255655393	-26.619331343649	1045.321024217498	12.0317636040177	0.9318	264	70	SKCM	NRAS	Approved in same tumor type	TRAMETINIB | COBIMETINIB | SORAFENIB
806.7095057450648	-5.30274922147441	798.4523520638363	-14.5967836400796	0.6754	264	8	SKCM	ZNF521	Experimental	LY2183240 | 2,4-DIDEOXY-DC-45-A2 | CIL41
753.217775900777	4.43439492916735	748.244878973372	0.433088518065063	0.6105	389	8	LUSC	ACACB	Clinical trials	ADENOSINE TRIPHOSPHATE | ADENOSINE 5&#39;-MONOPHOSPHATE
823.7913832562824	-8.41892908768139	821.9999053792585	-0.000572146974263887	0.6912	153	10	BLCA	TRIO	Clinical trials in cancer	141400-58-0 | GOSSYPOL | 7-ETHYL-10-HYDROXYCAMPTOTHECIN
863.8656193610102	1.13767419141797	866.4072895171452	-2.15812037399178	0.7409	512	31	UCEC	FGFR2	Approved in same tumor type	REGORAFENIB | PONATINIB | THALIDOMIDE
1050.9131857621608	-5.87276064284632	1050.1874970864271	-0.854932785133315	0.9368	543	27	LUAD	NF1	Approved in same tumor type	SORAFENIB | REGORAFENIB | SORAFENIB TOSYLATE
752.9411947730912	7.73837085501634	760.2299317009241	1.90822769308488	0.6226	423	15	COAD	ATR	Approved in same tumor type	PEMETREXED | IDARUBICIN | OLAPARIB
773.9819304762017	13.6106155484958	788.1410638681754	-4.6180853114854	0.6507	292	11	STAD	ROS1	Approved in same tumor type	CRIZOTINIB | CERITINIB | CABOZANTINIB
734.3153845100462	-7.72248871011888	739.1101606937099	-0.0276577666404592	0.6005	343	10	HNSC	PRKD1	Approved in other pathologies and in clinical trials in cancer	LOVASTATIN | LIFITEGRAST | EFALIZUMAB
771.3919499089966	-22.9849896568171	786.5500902075715	0.784626162178824	0.6503	389	23	LUSC	FBN2	Approved in cancer	ETOPOSIDE | RAPAMYCIN | PARTHENOLIDE
1025.433393452176	-5.64863871710739	1036.7446100814145	1.7104204428631	0.9339	512	69	UCEC	TP53	Approved in same tumor type	PACLITAXEL | ABT-199 | DOCETAXEL
756.0916492285487	18.1631359741764	760.1545674084355	-7.18675580280023	0.6421	264	16	SKCM	CSF2RB	Approved in same tumor type	BOSUTINIB | SORAFENIB | REGORAFENIB
793.4063728058535	-8.08431735552242	787.1380597108623	4.01396092680011	0.6534	292	7	STAD	FLT3	Approved in same tumor type	SORAFENIB | MIDOSTAURIN | CABOZANTINIB
734.4684818213348	5.49769565576798	739.1664925951508	1.39675734949924	0.6002	292	11	STAD	IGF1R	Approved in same tumor type	COPANLISIB | EVEROLIMUS | TEMSIROLIMUS
932.9504133437575	-2.88814225532508	927.9999758390899	0.000352100214740858	0.8091	117	4	KIRP	BRAF	Approved in same tumor type	TRAMETINIB | SORAFENIB | COBIMETINIB
892.5742586634834	-3.27160683567283	894.6068323145726	1.10931845316577	0.7708	512	13	UCEC	CDH1	Approved in other pathologies	UREA
928.5812496268867	-5.12517994758727	928.7481674483488	-4.22930763400018	0.8152	292	14	STAD	CDH1	Approved in other pathologies	UREA
802.0044140709182	-9.72031107982028	800.9797326531732	-2.02415386643383	0.6691	292	7	STAD	MAPK7	Approved in cancer	ARSENIC TRIOXIDE | THALIDOMIDE | LENALIDOMIDE
1036.0311535996116	-5.1267100048704	1028.0046703595397	-0.00288649918820738	0.9198	423	18	COAD	SMAD4	Approved in cancer	DASATINIB | PONATINIB | BOSUTINIB
912.6226213195098	-0.686943295866229	905.0000511287714	-0.000286539481066939	0.7835	599	32	GBM	PIK3CA	Approved in same tumor type	COPANLISIB | TRAMETINIB | COBIMETINIB
753.8857122995073	-11.834403724131	762.5730443458143	-12.3281295511179	0.6284	264	9	SKCM	RBL1	Approved in other pathologies	HEPARIN
760.3640835075842	9.38649553339695	758.9204891707235	-5.126908385359	0.6227	512	17	UCEC	NOS1	Approved in other pathologies	FELODIPINE | ADENOSINE TRIPHOSPHATE | VINPOCETINE
794.5373418689913	-5.46110672776595	789.334259688844	-0.310810675200628	0.6545	292	7	STAD	RHOA	Approved in cancer	COPANLISIB | THALIDOMIDE | BORTEZOMIB
899.4499132625392	-14.9838663841147	897.3096356435068	-0.0328454245754983	0.7805	153	18	BLCA	PIK3CA	Approved in same tumor type	COPANLISIB | TRAMETINIB | SORAFENIB
1021.2770597072584	9.44537579049495	1016.3788431270873	-2.29875125334797	0.9056	222	11	LGG	NF1	Approved in same tumor type	COBIMETINIB | REGORAFENIB | SORAFENIB TOSYLATE
756.479391453754	13.011340220273	756.2101284607995	-1.77940801984266	0.6189	389	10	LUSC	TLR4	Approved in other pathologies	USTEKINUMAB | GUSELKUMAB | FRESOLIMUMAB
1088.5807070837118	25.3243037333405	1033.8124083023877	0.854650229835897	0.9339	543	122	LUAD	TP53	Approved in same tumor type	PACLITAXEL | ABT-199 | DOCETAXEL
748.6932954518786	1.54343850085974	760.5539411760122	1.22136614602732	0.6213	512	13	UCEC	ITGAM	Approved in other pathologies and in clinical trials in cancer	SIMVASTATIN | FASUDIL | QUINACRINE, DIHYDROCHLORIDE
1010.3135524264461	0.353884275766831	1037.8859751461325	-10.8851013952758	0.9368	264	36	SKCM	NF1	Approved in same tumor type	TRAMETINIB | COBIMETINIB | SORAFENIB
974.7889664922717	-2.55225338595449	965.9999936620483	-0.000290628023776662	0.8516	934	57	BRCA	CDH1	Approved in other pathologies	UREA
979.6665683594579	-0.854437494325737	975.0000076347984	0.000235468764117286	0.8614	599	15	GBM	IDH1	Approved in same tumor type	ABT-199 | DASATINIB | BEVACIZUMAB
941.2368470578512	-5.27180264679899	931.9999522604572	-0.000534364346094662	0.8137	934	29	BRCA	PTEN	Approved in cancer	DASATINIB | BOSUTINIB | PONATINIB
742.4489355938885	-2.75831984313712	771.3228497875942	-2.42523719128531	0.6253	512	28	UCEC	ATR	Approved in same tumor type	OLAPARIB | PEMETREXED | IDARUBICIN
948.2063843942976	2.81322466817204	953.400057287303	8.53553080876782	0.8414	264	23	SKCM	PTEN	Approved in cancer	BOSUTINIB | COPANLISIB | PONATINIB
979.9852737176556	-11.6661784106198	938.9065989171401	-0.660496684865848	0.8396	264	30	SKCM	NLRP3	Approved in other pathologies and in clinical trials in cancer	EMRICASAN | VX-765 | LAX-101
798.9581082378063	-8.74360723724834	790.1399055879732	-1.95074132626678	0.6607	512	15	UCEC	LZTR1	Approved in cancer	BRD6368 | RO 28-1675 | BISTRAMIDE A
741.9626946812896	-16.5490968322569	753.1780319049751	-5.15817935962696	0.6105	264	16	SKCM	ACACB	Clinical trials	ADENOSINE TRIPHOSPHATE | ADENOSINE 5&#39;-MONOPHOSPHATE
1039.7960683267036	-4.87180215720304	1045.6534157706396	8.03947908653754	0.9368	934	19	BRCA	NF1	Approved in same tumor type	BOSUTINIB | TRAMETINIB | COBIMETINIB
748.6270602792989	8.94880536584458	750.6425012317986	4.03604338318996	0.6105	512	20	UCEC	ACACB	Clinical trials	ADENOSINE TRIPHOSPHATE | ADENOSINE 5&#39;-MONOPHOSPHATE
775.9634655649489	-30.7495178866475	778.8918092286668	19.2538432143378	0.6405	264	24	SKCM	LIFR	Approved in cancer	PEMETREXED | SELUMETINIB | 141400-58-0
786.8296588696495	-25.9322789700271	788.2830797591928	-18.9260456193138	0.6455	264	20	SKCM	MET	Approved in same tumor type	COPANLISIB | CRIZOTINIB | DASATINIB
1060.0898234670328	-66.4741656402384	1031.7497319803877	-11.8604667682052	0.9339	599	301	OV	TP53	Approved in same tumor type	DOCETAXEL | PACLITAXEL | ABT-199
801.0231688373835	1.07158751563509	800.4210083232344	-0.0904013944425515	0.6673	512	11	UCEC	MAPK7	Approved in cancer	ARSENIC TRIOXIDE | THALIDOMIDE | POMALIDOMIDE
791.2666832044168	29.092411669784	780.6094038027774	0.171623225114217	0.6457	543	34	LUAD	NLRP3	Approved in other pathologies and in clinical trials in cancer	ANAKINRA | VX-765 | EMRICASAN
768.0206995501627	-10.3566772636198	767.4689078566993	0.233252823530847	0.633	512	12	UCEC	TNIK	Clinical trials in cancer	STAUROSPORINE | CHM-1 | CYTOCHALASIN B
1047.4605898583497	-10.7800689243205	1052.1902328954616	-0.753835812938632	0.9452	423	21	COAD	TGFBR2	Experimental	3-(4-FLUOROPHENYL)-2-(6-METHYLPYRIDIN-2-YL)-5,6-DIHYDRO-4H-PYRROLO[1,2-B]PYRAZOLE | 396129-53-6 | 1132610-45-7
763.1392513812357	-10.6001353277237	755.2493439379351	-2.7825211707077	0.6167	292	17	STAD	HSPG2	Approved in same tumor type	SORAFENIB | REGORAFENIB | SORAFENIB TOSYLATE
785.9462663135471	-8.82550603847307	774.4809294228629	9.78969914228719	0.6365	264	6	SKCM	ERBB3	Approved in same tumor type	COPANLISIB | TEMSIROLIMUS | AFATINIB
1011.6528009090282	-18.5660372554853	1040.6326026142683	6.71535576752694	0.9339	423	76	COAD	TP53	Approved in same tumor type	ABT-199 | DOCETAXEL | ERIBULIN
934.4609044743131	-8.77072146015888	919.9993546348798	0.00163616216696028	0.8001	222	15	LGG	PIK3CA	Approved in same tumor type	COPANLISIB | SORAFENIB | DABRAFENIB
927.7763662170557	-10.9382126934267	940.0002075764293	-0.000241853970692318	0.8225	502	25	KIRC	MTOR	Approved in same tumor type	VANDETANIB | COPANLISIB | PONATINIB
737.5333156078218	-5.34088612206276	750.8023155851877	0.449094019493259	0.6123	264	10	SKCM	NCOA2	Clinical trials in cancer	GENISTEIN | 63676-22-2 | GW9662
842.6486829986845	-1.40568201382371	839.0000937338467	0.000507141470961869	0.71	292	19	STAD	ERBB4	Approved in same tumor type	COPANLISIB | AFATINIB | EVEROLIMUS
967.9071007073527	4.16704526875145	967.709739016997	0.14508260395246	0.8575	202	20	LAML	IDH2	Approved in same tumor type	DASATINIB | ABT-199 | OLAPARIB
763.1324795954737	-16.1387364183401	755.0654979087026	2.88003449420648	0.6307	264	9	SKCM	AGTR1	Approved in other pathologies and in clinical trials in cancer	DESMOPRESSIN | VASOPRESSIN | CONIVAPTAN
837.5832953170144	-0.593786591181328	839.0000190229492	0.000165767982252873	0.7095	343	7	HNSC	FGA	Approved in same tumor type	DASATINIB | BOSUTINIB | PONATINIB
820.4126196999185	1.09388049029013	818.000011317618	2.06157712909771e-05	0.6865	512	12	UCEC	BCL6	Clinical trials in cancer	ABT-737 | SELUMETINIB | AT13387
952.0826816323763	-15.6858809001187	964.8995526390539	3.63737141132242	0.8396	264	32	SKCM	KMT2A	Approved in same tumor type	DOXORUBICIN | CYTARABINE | DAUNORUBICIN
956.9516772196793	47.7947688019569	928.0013199390276	-0.00139285188129179	0.8091	435	183	THCA	BRAF	Approved in same tumor type	SORAFENIB | PACLITAXEL | REGORAFENIB
1075.304476524176	10.2826730168808	1075.9998198226724	0.000247269974352093	0.9737	543	60	LUAD	KRAS	Approved in same tumor type	SORAFENIB | REGORAFENIB | COPANLISIB
821.5179286754019	-2.89273672874899	820.0615488851961	0.359597233762543	0.6873	543	14	LUAD	PRKD1	Approved in other pathologies and in clinical trials in cancer	LOVASTATIN | LIFITEGRAST | EFALIZUMAB
794.1861270321624	16.771697928755	786.2800348924118	-0.953059280471962	0.6492	512	17	UCEC	ARHGEF12	Clinical trials in cancer	SERDEMETAN | FASUDIL | QUINACRINE, DIHYDROCHLORIDE
805.0335783426909	-2.35966506235579	807.2352390420172	0.00437020808385569	0.6754	153	4	BLCA	ZNF521	Experimental	LY2183240 | 2,4-DIDEOXY-DC-45-A2 | CIL41
774.9362632837607	-12.4181119849591	771.5934615418091	-0.000173230401287583	0.6351	423	13	COAD	LIFR	Approved in cancer	PEMETREXED | SERDEMETAN | FEDRATINIB
908.5207057418941	5.39582193421975	901.9998650403421	-5.74819050598308e-05	0.7805	543	11	LUAD	PIK3CA	Approved in same tumor type	COPANLISIB | SORAFENIB | REGORAFENIB
792.7998221563994	-3.37144755764311	790.9999145345101	-0.000359613911314227	0.6566	423	9	COAD	PDGFRA	Approved in same tumor type	SORAFENIB | REGORAFENIB | SUNITINIB
1000.2850618017361	-8.49725448977867	998.9996702935999	0.000236960388519947	0.888	202	15	LAML	NRAS	Approved in same tumor type	SORAFENIB | TRAMETINIB | COBIMETINIB
735.4937672695874	1.84225172367843	743.9259559887066	0.434547805527473	0.6044	543	14	LUAD	FN1	Approved in cancer	BOSUTINIB | DASATINIB | PONATINIB
752.010625677976	1.63114784916189	758.17859039906	5.16824285153098	0.6234	264	8	SKCM	PAX8	Clinical trials	NAKITERPIOSIN | 7-ETHYL-10-HYDROXYCAMPTOTHECIN
744.6764098603535	10.3169408948783	750.8843049335715	-1.16363358678086	0.6121	389	12	LUSC	TRRAP	Approved in other pathologies	141400-58-0 | MK-1775 | LEXIBULIN
1004.3540726416227	8.33757668848125	1012.1006799968472	-0.928301237285268	0.8985	264	8	SKCM	PTPN11	Approved in same tumor type	SORAFENIB | COPANLISIB | REGORAFENIB
731.4950796548019	-5.12076405282212	741.1335036483747	-1.91034181954956	0.6007	543	19	LUAD	ERBB4	Approved in same tumor type	EVEROLIMUS | COPANLISIB | ADO-TRASTUZUMAB EMTANSINE
917.5407414983439	2.98386235020544	931.784364208427	6.03404614628016	0.813	264	13	SKCM	MAP2K1	Approved in same tumor type	BOSUTINIB | COBIMETINIB | ARSENIC TRIOXIDE
757.3688244632559	0.593056083539551	754.6545487888418	-0.0241287945214026	0.6149	543	18	LUAD	TRRAP	Approved in other pathologies	141400-58-0 | CURCUMIN | LEXIBULIN
742.0315745395	14.8745964899458	754.1023390333147	11.4150617101145	0.6219	264	15	SKCM	ITGAM	Approved in other pathologies and in clinical trials in cancer	SIMVASTATIN | FASUDIL | QUINACRINE, DIHYDROCHLORIDE
760.3842242280988	4.47266266293323	741.5864680465983	-1.59104798124986	0.6044	512	25	UCEC	FN1	Approved in cancer	DASATINIB | BOSUTINIB | PONATINIB
755.097183697173	-5.53328067382776	749.0035959844332	-0.00145221389379913	0.61	292	6	STAD	ITGAM	Approved in other pathologies and in clinical trials in cancer	SIMVASTATIN | FASUDIL | QUINACRINE, DIHYDROCHLORIDE
828.3404215834815	-5.22955838012163	831.1723562246534	-0.63049133234972	0.7006	264	7	SKCM	LZTR1	Approved in cancer	BRD6368 | RO 28-1675 | BISTRAMIDE A
951.2503795505309	-3.84726587906218	946.5686960358123	-2.81802946766175	0.8333	512	18	UCEC	KMT2A	Approved in same tumor type	PANOBINOSTAT | ROMIDEPSIN | BELINOSTAT
772.7464151942947	-0.526608666440296	775.0618436577286	-0.147554294521342	0.6382	153	4	BLCA	CHUK	Approved in cancer	PACLITAXEL | CABOZANTINIB | ABT-199
1031.6049963695461	2.07425867988596	1027.9971649566735	-0.00526743472028102	0.9201	264	8	SKCM	LMNA	Clinical trials in cancer	INDISULAM | ZEBULARINE | NUTLIN-3
921.6575592825592	-2.9185646613787	919.9998780598073	3.97526182496222e-05	0.7995	543	11	LUAD	SOS1	Approved in same tumor type	SORAFENIB | COBIMETINIB | DASATINIB
902.7855053565365	-6.06275060617318	902.0000379384952	-0.000240243091411685	0.7805	502	12	KIRC	PIK3CA	Approved in same tumor type	COPANLISIB | PACLITAXEL | PALBOCICLIB
780.5340239803478	-1.80352310081568	784.937179287675	-0.974116517778839	0.6493	153	4	BLCA	MAP3K4	Clinical trials in cancer	ABT-751 | LY2183240 | ELCPK
807.5659842217543	3.26745643423922	799.7963507177446	0.370616243594668	0.6662	292	6	STAD	PRKD1	Approved in other pathologies and in clinical trials in cancer	LOVASTATIN | LIFITEGRAST | EFALIZUMAB
1043.1216225013432	18.1633802086947	1046.9999940820553	-0.000141619389069092	0.9415	202	53	LAML	FLT3	Approved in same tumor type	SUNITINIB | SORAFENIB | MIDOSTAURIN
916.5468469177983	-6.9741144262895	929.4405798738244	-4.53060886215462	0.8082	264	15	SKCM	TRIO	Clinical trials in cancer	141400-58-0 | FEDRATINIB | GOSSYPOL
750.24719976524	-0.957617057600913	757.6048271989821	5.62809211723447	0.6204	512	12	UCEC	AGAP2	Approved in cancer	COPANLISIB | PKI-587 | PX-866
802.2189619811855	-1.37131140394825	796.0000000344527	-0.000135045843762782	0.6623	423	10	COAD	SMAD2	Approved in cancer	DASATINIB | BOSUTINIB | AXITINIB
814.1739470182068	-0.533985728825087	804.0012660356008	1.33938002813647	0.6694	292	15	STAD	TLR4	Approved in other pathologies	USTEKINUMAB | GUSELKUMAB | FRESOLIMUMAB
820.2447257463023	5.64353265336791	816.9386356012776	-0.35853886014047	0.6869	543	15	LUAD	TRIO	Clinical trials in cancer	141400-58-0 | GOSSYPOL | FEDRATINIB
876.2632039267586	-6.67684602104669	879.9998628912763	-9.81134835456032e-05	0.7556	264	19	SKCM	INSR	Approved in same tumor type	TEMSIROLIMUS | COPANLISIB | RAPAMYCIN
755.7107415102053	10.1041619477746	751.9786942576856	0.40637306155736	0.6145	512	13	UCEC	APAF1	Approved in cancer	OLAPARIB | NIRAPARIB | RUCAPARIB
809.7201214645947	-2.94599671420787	808.0000513126215	-2.38256096736222e-05	0.6761	389	13	LUSC	ERBB4	Approved in same tumor type	AFATINIB | LAPATINIB | COPANLISIB
819.4853842566215	27.1597151190628	792.9140473351213	26.2623129915901	0.6455	264	45	SKCM	NOS1	Approved in other pathologies	FELODIPINE | ADENOSINE TRIPHOSPHATE | VINPOCETINE
771.4893507976495	4.64899433383695	772.9916955765349	0.00188349701323887	0.6372	389	8	LUSC	MTOR	Approved in same tumor type	PACLITAXEL | COPANLISIB | DOCETAXEL
795.2226428469215	8.32857914252929	808.3009980718444	1.93208934223276	0.6671	264	11	SKCM	CAMK4	Approved in cancer	AMINOPHYLLINE | FELODIPINE | AMRINONE
769.0893729668978	6.13890713848684	779.4700579810112	-10.9138973447316	0.6316	264	7	SKCM	AGAP2	Approved in cancer	COPANLISIB | PKI-587 | PX-866
782.9819525467415	40.0749297212489	817.2887839156498	-9.92800938013352	0.6522	264	44	SKCM	ROS1	Approved in same tumor type	CRIZOTINIB | CABOZANTINIB | CERITINIB
1058.2059055563134	-14.6656285512321	1038.886048841655	4.90404592482071	0.9339	599	84	GBM	TP53	Approved in same tumor type	ABT-199 | PACLITAXEL | BORTEZOMIB
922.1344387399561	0.509869563024807	928.2434507095	2.54127021114209	0.8091	423	16	COAD	MTOR	Approved in same tumor type	EVEROLIMUS | TEMSIROLIMUS | PAZOPANIB
775.4942881643275	0.17378108025548	766.7529286800576	-2.36542566607818	0.6402	512	11	UCEC	MAP4K3	Approved in same tumor type	COBIMETINIB | ARSENIC TRIOXIDE | BOSUTINIB
788.2426845573999	12.8339924839058	781.8989721183682	-1.95710808038058	0.6478	389	12	LUSC	RB1	Approved in same tumor type	PONATINIB | BOSUTINIB | ARSENIC TRIOXIDE
853.0000060324037	8.74206483558737e-06	853.0000275755231	8.53060828376329e-05	0.7252	264	8	SKCM	RAF1	Approved in same tumor type	SORAFENIB | TRAMETINIB | COBIMETINIB
968.9596569732129	-35.6760116381005	967.5285696616819	-3.75864307550728	0.8414	512	161	UCEC	PTEN	Approved in cancer	DASATINIB | BOSUTINIB | PONATINIB
1044.8382904585192	0.431760566826313	1041.921601780761	-2.55586657001777	0.9368	292	10	STAD	NF1	Approved in same tumor type	REGORAFENIB | DABRAFENIB | TRAMETINIB
752.6616628450873	-5.01935603288268	755.6405980350967	-5.03248539590959	0.6176	512	11	UCEC	ZFYVE9	Experimental	O-PHOSPHO-L-SERINE
773.5576139657519	6.16403471485404	767.3969921493099	-4.98194977003459	0.6311	512	12	UCEC	DDR2	Approved in same tumor type	DASATINIB | REGORAFENIB | SORAFENIB
862.0681069394857	-13.9334194400849	880.675530479383	-4.82035475857992	0.7576	343	66	HNSC	CDKN2A	Approved in cancer	ARSENIC TRIOXIDE | PALBOCICLIB | RIBOCICLIB
745.6871007270738	1.28173836301295	743.0000207973169	0.000605411134188216	0.6036	117	3	KIRP	TRIO	Clinical trials in cancer	141400-58-0 | GOSSYPOL | FEDRATINIB
905.8506511092763	-36.5564463130549	915.4713952965507	0.39357901043013	0.8001	512	132	UCEC	PIK3CA	Approved in same tumor type	COPANLISIB | EVEROLIMUS | TRASTUZUMAB
741.5010918159888	-7.78827011776167	743.7458401861124	-2.20519413899291	0.6048	389	12	LUSC	NLRP3	Approved in other pathologies and in clinical trials in cancer	VX-765 | EMRICASAN | LAX-101
791.073996116213	-9.99219743870111	787.3955372708002	0.97494590982069	0.6518	153	4	BLCA	RHOA	Approved in cancer	COPANLISIB | BORTEZOMIB | THALIDOMIDE
1006.4698740415793	36.5090740517894	1082.8420479089511	-0.00490920415251139	0.9737	57	24	PAAD	KRAS	Approved in same tumor type	ARSENIC TRIOXIDE | COPANLISIB | REGORAFENIB
761.3380622652138	-0.420399338407208	761.9999944339851	0.000250483375566546	0.6248	222	8	LGG	EGFR	Approved in same tumor type	SORAFENIB | BOSUTINIB | DABRAFENIB
882.9505371418536	-22.9299141034606	905.0405504149298	0.0894659239997964	0.7805	343	64	HNSC	PIK3CA	Approved in same tumor type	COPANLISIB | SORAFENIB | REGORAFENIB
777.6197103284978	-6.88137179820913	771.9754018961968	0.763605224680532	0.6355	292	7	STAD	JAK2	Approved in same tumor type	RUXOLITINIB | PACLITAXEL | RUXOLITINIB PHOSPHATE
806.9696331398843	17.6940950051535	791.7314711181598	2.14406568933418	0.6495	264	24	SKCM	PDGFRA	Approved in same tumor type	SORAFENIB | REGORAFENIB | SUNITINIB
784.7141709423041	-0.820170800601147	791.7085123977206	1.05842739720538	0.6539	153	7	BLCA	KDR	Approved in same tumor type	SORAFENIB | REGORAFENIB | SORAFENIB TOSYLATE
1073.0046414754122	-22.4708622856265	1075.9998296805832	0.000299225456728891	0.9737	423	59	COAD	KRAS	Approved in same tumor type	SORAFENIB | REGORAFENIB | COPANLISIB
759.2591118035217	-7.93199084489657	762.6084708721853	-0.271818333708893	0.624	389	8	LUSC	RASA1	Approved in same tumor type	COBIMETINIB | SORAFENIB | REGORAFENIB
795.4623912748638	-2.80147019712777	786.6124889720699	-1.25009683552275	0.657	292	7	STAD	IKBKE	Approved in cancer	GALIXIMAB | SMR000449312 | TARENFLURBIL
804.5667939349792	1.44836797074194	797.4298166393552	7.286569311515	0.6606	264	10	SKCM	BLNK	Approved in other pathologies and in clinical trials in cancer	VITAMIN E | ENZASTAURIN | SOTRASTAURIN ACETATE
991.4900929827587	-11.0004542203795	987.999892079294	-0.00027400029648561	0.875	153	12	BLCA	CREBBP	Approved in same tumor type	ARSENIC TRIOXIDE | SORAFENIB | PONATINIB
814.7349279397528	4.34316988351051	810.7753136651639	0.0549884517581631	0.6781	423	9	COAD	ZNF521	Experimental	2,4-DIDEOXY-DC-45-A2 | CIL41 | LY2183240
758.5984699164504	-2.51306731024275	762.000077409824	0.00082396812723573	0.6243	134	3	CESC	NF1	Approved in same tumor type	SORAFENIB | REGORAFENIB | SORAFENIB TOSYLATE
822.3464804324852	-17.6860616472604	809.8229612691821	9.73255878680311	0.6792	264	24	SKCM	HSPG2	Approved in same tumor type	REGORAFENIB | SORAFENIB | SORAFENIB TOSYLATE
779.3904579667171	13.3183531741712	769.2784259488008	2.89071443536113	0.633	264	14	SKCM	SYK	Approved in same tumor type	COPANLISIB | ARSENIC TRIOXIDE | COBIMETINIB
749.7828259670846	17.5002583053658	761.2303614239637	-0.0760896794199653	0.6243	153	7	BLCA	NF1	Approved in same tumor type	REGORAFENIB | DABRAFENIB | BOSUTINIB
756.6839304975227	-7.57694210420854	763.5226055570433	-3.47664335047193	0.6237	264	6	SKCM	FYN	Approved in cancer	COPANLISIB | PAZOPANIB | BEVACIZUMAB
759.2576639297536	-13.8847279311126	763.4329641695629	0.0799334721777996	0.6256	423	11	COAD	ROS1	Approved in same tumor type	CRIZOTINIB | CABOZANTINIB | CERITINIB
870.5019609422208	-1.78984281664728	874.0000005834274	0.00025785293445324	0.7493	389	21	LUSC	NF1	Approved in same tumor type	TRAMETINIB | COBIMETINIB | SORAFENIB
770.5729264062194	11.8708209242993	771.9384004100559	0.146504540484329	0.6372	153	4	BLCA	PSIP1	Approved in cancer	PALBOCICLIB | 141400-58-0 | LY2183240
801.537750726004	-14.1193719622886	800.0794580347647	-0.00692884548698203	0.6667	543	27	LUAD	TLR4	Approved in other pathologies	USTEKINUMAB | GUSELKUMAB | FRESOLIMUMAB
859.2498079480677	-1.16648216948616	862.343833183428	1.01603095927408	0.7373	512	13	UCEC	STAT1	Approved in same tumor type	RUXOLITINIB | ABT-199 | COPANLISIB
775.930687030863	19.1935202677274	797.5463559840412	13.1954797943586	0.6597	264	16	SKCM	RAC1	Approved in same tumor type	TRAMETINIB | COBIMETINIB | SORAFENIB
760.4203599811785	27.1100536666564	768.5068171049604	15.2310992385751	0.6336	264	25	SKCM	CACNA1D	Approved in other pathologies and in clinical trials in cancer	VERAPAMIL | CELECOXIB | VERAPAMIL HYDROCHLORIDE
780.5015855657988	7.30820948958484	777.151050741652	-0.368815522138959	0.6423	389	19	LUSC	ROS1	Approved in same tumor type	CRIZOTINIB | CABOZANTINIB | CERITINIB
942.5656793408942	-2.38682760275373	947.0008780217922	-5.09494316035943	0.8238	389	8	LUSC	BRAF	Approved in same tumor type	ARSENIC TRIOXIDE | SORAFENIB | REGORAFENIB
1048.3078447728083	-1.12722237552572	1054.2144411605534	-5.29361816992423	0.9409	343	10	HNSC	TGFBR2	Experimental	3-(4-FLUOROPHENYL)-2-(6-METHYLPYRIDIN-2-YL)-5,6-DIHYDRO-4H-PYRROLO[1,2-B]PYRAZOLE | 396129-53-6 | 1132610-45-7
791.7454222632232	-5.84242623431982	789.6168538244991	2.55473244415361	0.6539	292	7	STAD	FER	Approved in other pathologies	UREA
809.6592212989144	1.17241146921418	810.0000779180494	0.000208363370347797	0.6782	343	10	HNSC	HRAS	Approved in same tumor type	SORAFENIB | TRAMETINIB | COPANLISIB
773.7177879285305	2.68559159636152	764.9999401375914	0.000133098859009806	0.6273	169	5	READ	SMAD2	Approved in cancer	DASATINIB | PALBOCICLIB | BOSUTINIB
767.4743164698052	-14.7626578172216	778.3078233291398	-14.8111050644761	0.6221	264	11	SKCM	DCN	Approved in other pathologies	GLYCEROL | USTEKINUMAB | GUSELKUMAB
731.9870674644988	-15.4975288282931	742.6269326510437	7.5468112900071	0.6031	264	28	SKCM	ITGA4	Approved in cancer	COPANLISIB | CAPTOPRIL | ALPELISIB
793.1143414272568	4.29532822826496	793.4688712412463	-2.63076871402495	0.6582	512	14	UCEC	KDR	Approved in same tumor type	SORAFENIB | SUNITINIB | REGORAFENIB
747.3571584761279	13.247348740046	754.0849381951941	1.25194939398932	0.615	389	14	LUSC	ABCB1	Approved in same tumor type	PACLITAXEL | ETOPOSIDE | IMATINIB
753.679978552126	-8.0924729379407	757.3214053367069	-0.584106906358102	0.6199	423	12	COAD	TPR	Approved in cancer	PEMETREXED | SERDEMETAN | CHM-1
798.4239005776191	13.2769013306332	783.1717174393739	-5.35853327926907	0.6439	512	29	UCEC	AKAP9	Clinical trials in cancer	ZEBULARINE | FQI1 | ISOEVODIAMINE
725.573421076921	10.9671730453006	743.2541394891964	-11.5588481936243	0.6121	264	36	SKCM	TRRAP	Approved in other pathologies	141400-58-0 | LEXIBULIN | MK-1775
819.4243984861406	-5.14134091860149	815.9998468930453	0.000652452619135602	0.6839	389	10	LUSC	PRKD1	Approved in other pathologies and in clinical trials in cancer	LOVASTATIN | LIFITEGRAST | EFALIZUMAB
925.128257035714	7.46506431497374	937.5150569229613	0.236624676157362	0.8137	292	7	STAD	PTEN	Approved in cancer	DASATINIB | BOSUTINIB | COPANLISIB
899.3846256266978	2.58042947966402	888.3006257015694	0.236928826693884	0.7657	512	14	UCEC	AR	Approved in cancer	ENZALUTAMIDE | BICALUTAMIDE | DANAZOL
749.6271303191954	-10.3622162209554	785.9520573733073	15.6066676390124	0.6353	264	11	SKCM	IL1R1	Approved in cancer	COBIMETINIB | TRAMETINIB | BOSUTINIB
1039.7153154374462	-8.42794060173264	1045.9661256657068	-3.16453401126614	0.9368	512	20	UCEC	NF1	Approved in same tumor type	TRAMETINIB | COBIMETINIB | SORAFENIB
805.4785303073029	-8.96680274769113	796.8155608066769	1.75713103201042	0.6636	292	10	STAD	KDR	Approved in same tumor type	PONATINIB | BOSUTINIB | COPANLISIB
788.842966317411	-7.37709498373644	779.893965046811	-1.22689026355965	0.6502	512	16	UCEC	ITGAL	Approved in cancer	MIDOSTAURIN | RUXOLITINIB | INGENOL MEBUTATE
802.2244995097033	30.042744385928	771.0046160632451	-8.36112680716678	0.6629	264	32	SKCM	KDR	Approved in same tumor type	SORAFENIB | SUNITINIB | REGORAFENIB
779.1371488083887	-21.5374717591021	773.4859263777305	-19.6401209606497	0.6414	264	19	SKCM	FLT4	Approved in same tumor type	SUNITINIB | AXITINIB | PAZOPANIB
789.5184489136543	17.1327652476284	797.782022571018	-3.07504373255597	0.6621	512	23	UCEC	ABCB1	Approved in same tumor type	PACLITAXEL | ETOPOSIDE | CARBOPLATIN
918.5593403316217	-1.8977592159824	924.0160381146799	-2.84794629991302	0.8055	292	10	STAD	FLNA	Approved in cancer	ARSENIC TRIOXIDE | VINBLASTINE | CC-401
956.4911552809476	13.9291135025774	917.5335961362138	-6.31176181124238	0.8089	264	38	SKCM	TP53	Approved in same tumor type	DOCETAXEL | PACLITAXEL | ABT-199
868.818688000816	2.7160398452948	869.963619961062	2.75433814934058	0.7493	343	9	HNSC	NF1	Approved in same tumor type	TRAMETINIB | COBIMETINIB | SORAFENIB
774.9609402895683	28.0809866938007	792.6990572573428	0.575098754191458	0.6503	543	40	LUAD	FBN2	Approved in cancer	ETOPOSIDE | RAPAMYCIN | PARTHENOLIDE
920.7687700880577	-13.7010849771939	924.3588704978798	4.96959179635041	0.8039	264	20	SKCM	GNAS	Approved in cancer	DASATINIB | BOSUTINIB | RUXOLITINIB
795.3671521817357	-12.4881460125166	764.2908099411654	7.18373914211452	0.649	264	15	SKCM	DRD2	Clinical trials	ELLAGIC ACID | FASUDIL | ADENOSINE TRIPHOSPHATE
815.5866392692399	11.0074879585415	804.505610528066	-18.6512505131227	0.6645	264	24	SKCM	TLR4	Approved in other pathologies	USTEKINUMAB | GUSELKUMAB | FRESOLIMUMAB
755.8531259349443	-15.7625016206253	748.128455033552	0.079753711909234	0.6133	512	20	UCEC	LRP6	Approved in other pathologies	AT9283 | ENZASTAURIN | VANTICTUMAB
772.046144304645	-4.07219879476369	765.5852319442768	-0.754313395220834	0.6357	264	9	SKCM	BDKRB2	Experimental	GUANOSINE 5&#39;-DIPHOSPHATE
760.3691126065097	13.8001756638516	752.3302718316534	2.41268539171028	0.6142	292	12	STAD	NCOA2	Clinical trials in cancer	GENISTEIN | 63676-22-2 | GW9662
762.7435568863588	18.6658178565727	751.3801082548424	-4.21888965238327	0.6223	512	26	UCEC	FLNA	Approved in cancer	ARSENIC TRIOXIDE | VINBLASTINE | CC-401
789.8862643806686	-14.1743772657471	788.397976927984	-2.81847326547449	0.653	153	6	BLCA	FBN2	Approved in cancer	ETOPOSIDE | RAPAMYCIN | PARTHENOLIDE
740.4684392484444	-11.3534916392289	739.2876106253228	1.48827465188788	0.6001	543	16	LUAD	PDGFRA	Approved in same tumor type	IMATINIB | SORAFENIB | PONATINIB
757.6139097017152	-5.03458605420033	755.0174091293784	-0.513213870442542	0.6164	264	6	SKCM	NGF	Approved in cancer	BOSUTINIB | COPANLISIB | ARSENIC TRIOXIDE
825.733844219838	-2.99260345880285	826.9999780012482	5.72405751881888e-05	0.6962	423	13	COAD	TRPS1	Approved in cancer	NUTLIN-3 | BIX-01294 | TIPIFARNIB-P2
806.1029695621207	-12.7914044306205	806.196114422549	-1.83834286612273	0.667	264	8	SKCM	FGFR3	Approved in same tumor type	PONATINIB | PAZOPANIB | SORAFENIB
789.3357743377909	7.66768851645094	792.779758765978	-6.68359046900423	0.6547	264	15	SKCM	MAP3K4	Clinical trials in cancer	FEDRATINIB | ABT-751 | LY2183240
1028.7380067419945	3.07157308134916	1036.6919084755798	-15.8880445858849	0.9198	343	7	HNSC	SMAD4	Approved in cancer	PALBOCICLIB | RIBOCICLIB | BOSUTINIB
765.1220344872478	-5.76643839575635	759.5895792085552	8.00780409989693	0.6271	264	6	SKCM	EWSR1	Approved in cancer	IDARUBICIN | PAC-1
818.7546780864999	-1.40295595263402	813.6789870577207	1.10384784323833	0.6845	264	7	SKCM	ARNT	Approved in same tumor type	SORAFENIB | SUNITINIB | AXITINIB
731.5124631652362	1.82062949846357	746.4562936725232	-0.000835659259337262	0.6062	343	14	HNSC	EGFR	Approved in same tumor type	SORAFENIB | BOSUTINIB | DABRAFENIB
1025.3328491890459	5.28867425907839	1027.9999022464162	0.000738069698968502	0.9198	169	8	READ	SMAD4	Approved in cancer	DASATINIB | PONATINIB | BOSUTINIB
933.9050727112957	-27.0140869755596	928.2706567526616	12.8228954671122	0.8089	292	69	STAD	TP53	Approved in same tumor type	PACLITAXEL | ABT-199 | DOCETAXEL
771.1136147049593	16.5850866161638	774.9766543093018	0.000142875558140076	0.6393	543	17	LUAD	GLI3	Approved in cancer	VISMODEGIB
977.8910629716261	1.71103630033497	963.9679321937462	-13.0871003103607	0.8575	222	6	LGG	IDH2	Approved in same tumor type	DASATINIB | ABT-199 | OLAPARIB
866.2727017663966	6.46343174777985	871.2487046151606	1.14213525881451	0.7437	512	19	UCEC	CHD8	Approved in cancer	ARSENIC TRIOXIDE | SULINDAC | MARIMASTAT
905.6095406727864	1.03363698459322	902.0000159046494	0.000449893293904324	0.7805	134	9	CESC	PIK3CA	Approved in same tumor type	COPANLISIB | SORAFENIB | PONATINIB
744.8304423618627	-6.98755834606573	742.4333041830035	0.0283340512683026	0.602	343	9	HNSC	HLA-A	Clinical trials	SODIUM STIBOGLUCONATE
1070.2563550456612	3.73212824157008	1063.9999145222675	0.000473156701445987	0.9603	292	8	STAD	RB1	Approved in same tumor type	DASATINIB | PONATINIB | BOSUTINIB
939.7923365755881	18.4990297575189	942.1922538328455	7.03543405238406	0.8333	512	74	UCEC	CTNNB1	Approved in same tumor type	ARSENIC TRIOXIDE | LENALIDOMIDE | VINBLASTINE
1094.4307721081877	-34.9728520992028	1038.3449861545314	-8.04382741697964	0.9339	934	256	BRCA	TP53	Approved in same tumor type	PACLITAXEL | ABT-199 | DOCETAXEL
772.5660876647019	-16.6374700701071	757.6840838946124	-13.3033821832983	0.6412	264	13	SKCM	RET	Approved in same tumor type	SUNITINIB | VANDETANIB | CABOZANTINIB
877.7426248677791	51.5395789385203	928.9560744353807	10.1134929814934	0.8089	389	145	LUSC	TP53	Approved in same tumor type	PACLITAXEL | ABT-199 | DOCETAXEL
1015.3537488405888	9.97320900228209	1009.4753453429158	-0.00481798461669314	0.9001	202	9	LAML	PTPN11	Approved in same tumor type	SORAFENIB | COPANLISIB | SORAFENIB TOSYLATE
1047.7803808128876	1.85079039714753	1052.2509110407177	11.8601038980592	0.9368	599	12	OV	NF1	Approved in same tumor type	TRAMETINIB | COBIMETINIB | BOSUTINIB
838.4732296649962	1.89509373834531	838.999849545935	3.81590662072995e-05	0.7095	423	10	COAD	FGA	Approved in same tumor type	BOSUTINIB | PONATINIB | DASATINIB
957.9927773613995	-3.24447078105359	956.00238472964	-0.0124450359262482	0.8401	264	9	SKCM	CHRNA4	Approved in other pathologies and in clinical trials in cancer	NICOTINE | PHENOBARBITAL | PYRIDOXINE
802.5708183052409	6.05213296764026	780.6251529416697	-1.05978999036597	0.6487	153	7	BLCA	NIN	Clinical trials in cancer	LY2183240 | GW843682X | PARBENDAZOLE
754.9751525561743	2.60626179298731	755.8965175306698	3.5433392790469	0.6221	512	11	UCEC	DCN	Approved in other pathologies	GLYCEROL | USTEKINUMAB | GUSELKUMAB
736.1319911684211	13.4877110711864	741.668564605124	-2.85287739501132	0.6024	292	13	STAD	TIAM1	Clinical trials	QUERCETIN | GUANOSINE 5&#39;-DIPHOSPHATE | BISINDOLYLMALEIMIDE I
757.4057008659096	7.6754939910997	762.9999407607462	0.000298408444905363	0.6253	543	13	LUAD	VWF	Approved in cancer	COPANLISIB | BOSUTINIB | PONATINIB
766.087299412546	6.23798917799752	774.4388816368103	2.24932810955488	0.6364	292	7	STAD	CSNK2A1	Approved in cancer	THALIDOMIDE | ASPIRIN | AT9283
773.9435271081076	-6.92238230956534	774.8557623522458	-0.00155307745308164	0.6393	423	10	COAD	GLI3	Approved in cancer	VISMODEGIB
887.8277017691664	-4.89680274953406	886.9998227594506	0.000469642704842954	0.7635	169	4	READ	VWF	Approved in cancer	COPANLISIB | BOSUTINIB | PONATINIB
817.6954799455242	3.07586684423356	810.7646403424496	-0.00422428726460566	0.6782	153	5	BLCA	HRAS	Approved in same tumor type	TRAMETINIB | COPANLISIB | ARSENIC TRIOXIDE
897.3146953973345	-0.0862904843137358	897.9999034735978	0.000676725431731029	0.7752	169	5	READ	ERBB2	Approved in same tumor type	COPANLISIB | ADO-TRASTUZUMAB EMTANSINE | AFATINIB
755.87446841397	5.18404495455462	758.9999553840281	-0.000270054510565387	0.6213	543	14	LUAD	ITGAM	Approved in other pathologies and in clinical trials in cancer	SIMVASTATIN | FASUDIL | QUINACRINE, DIHYDROCHLORIDE
937.6866808682219	-2.38459030179581	945.9307821092108	5.80580088322768	0.822	264	12	SKCM	CTNNB1	Approved in same tumor type	ARSENIC TRIOXIDE | BEVACIZUMAB | LENALIDOMIDE
743.3203220689462	2.66828040409618	746.652039362539	-0.0118220703348015	0.6069	543	11	LUAD	NTRK1	Approved in same tumor type	REGORAFENIB | SORAFENIB | DABRAFENIB
884.0655741783752	12.9111820604006	905.0004056815727	-0.00110700090590399	0.7835	934	261	BRCA	PIK3CA	Approved in same tumor type	COPANLISIB | PACLITAXEL | TRAMETINIB
942.0410222715119	-10.9205362197265	949.5519023299659	0.29847075892576	0.823	264	17	SKCM	BTK	Approved in cancer	ARSENIC TRIOXIDE | MIDOSTAURIN | ACALABRUTINIB
740.8135783009807	1.72544765095415	745.8066554799043	-3.01182623823752	0.6071	512	13	UCEC	ZNF521	Experimental	2,4-DIDEOXY-DC-45-A2 | CIL41 | LY2183240
927.8139494312074	8.73527121119781	931.9995474493281	6.37908451608382e-05	0.8136	343	9	HNSC	RAC1	Approved in same tumor type	COPANLISIB | TRAMETINIB | COBIMETINIB
975.0050269268547	2.47429326022964	975.9991170704646	-0.000595483856159262	0.862	264	6	SKCM	GNA11	Approved in same tumor type	SORAFENIB | REGORAFENIB | MIDOSTAURIN
779.4721504091044	-10.9825126622846	760.4087614801614	12.2475723271423	0.6263	264	13	SKCM	TLR9	Approved in cancer	IMIQUIMOD | HYDROXYCHLOROQUINE | RESIQUIMOD
793.3258225222374	-19.8963943621509	801.4900361113397	2.11652084610932	0.6407	264	19	SKCM	ITGAL	Approved in cancer	MIDOSTAURIN | RUXOLITINIB | INGENOL MEBUTATE
789.6375649699296	1.59614023842019	789.3323543245127	-11.7379916344748	0.6481	264	12	SKCM	CAMK1D	Approved in other pathologies	APREMILAST | SAPROPTERIN | MICONAZOLE
783.7860994644009	23.7170695812866	783.9782062410793	-5.52772211948923	0.6331	264	24	SKCM	NLRP1	Clinical trials	VX-765 | EMRICASAN | LAX-101
946.2135675306131	-5.30103388114375	946.7167238911212	-0.123139448000529	0.8202	153	8	BLCA	FGFR3	Approved in same tumor type	PONATINIB | PAZOPANIB | SORAFENIB
899.8324972537544	-6.01170358855083	896.5694499232523	-1.22140683361545	0.7748	512	13	UCEC	NONO	Clinical trials in cancer	GOSSYPOL | NEOPELTOLIDE | STK178014
750.9709597022376	-6.84692187511112	758.4294940572762	3.06171659563779	0.6248	512	11	UCEC	TAB2	Approved in same tumor type	COBIMETINIB | THALIDOMIDE | ARSENIC TRIOXIDE
998.9621527162491	8.64788463863374	998.9999554755793	0.000297408162168722	0.888	435	26	THCA	NRAS	Approved in same tumor type	TRAMETINIB | COBIMETINIB | SORAFENIB
789.1058808913718	-3.29442862888376	773.5884016459341	6.27364097905411	0.6455	264	10	SKCM	CSF1R	Approved in cancer	COPANLISIB | ALPELISIB | DACTOLISIB
928.8710362911164	2.49314559077791	927.9999590755049	0.000494144083631909	0.8089	202	16	LAML	TP53	Approved in same tumor type	PACLITAXEL | ABT-199 | BORTEZOMIB
1067.6725203572555	-3.75462335782086	1075.9999629406252	0.00032981754930006	0.9737	512	53	UCEC	KRAS	Approved in same tumor type	SORAFENIB | REGORAFENIB | COPANLISIB
1055.9558190408657	-3.82237195655867	1047.2887552292812	1.45452141275882	0.9397	512	21	UCEC	TRIO	Clinical trials in cancer	GOSSYPOL | FEDRATINIB | 141400-58-0
734.5143632057714	-1.89412793592609	750.3454264944656	0.0241075757603539	0.6129	543	21	LUAD	ZNF521	Experimental	LY2183240 | 2,4-DIDEOXY-DC-45-A2 | CIL41
778.9573081832739	0.886698748983036	773.4169937434123	1.89858498626154	0.635	512	13	UCEC	TRIP11	Approved in same tumor type	32703-82-5 | PIK-75 | 4-METHYLFASUDIL
1073.7781355385416	1.74271289097817	1063.9942707546209	-0.000880471803156979	0.9603	264	9	SKCM	RB1	Approved in same tumor type	DASATINIB | IMATINIB | PONATINIB
775.7205847000723	-8.94502747636284	772.8252515168599	0.100334211033442	0.6381	264	6	SKCM	E2F1	Approved in same tumor type	BOSUTINIB | ARSENIC TRIOXIDE | PALBOCICLIB
744.5100351307502	22.2000028878072	764.9649291629595	-18.2150263978324	0.6287	264	19	SKCM	PRKCB	Approved in cancer	ARSENIC TRIOXIDE | SULFASALAZINE | AURANOFIN
777.4263383213569	-15.4244364594622	768.7410188175437	-0.555706188742079	0.6328	292	10	STAD	FLT4	Approved in same tumor type	AXITINIB | PAZOPANIB | SORAFENIB
938.5901651076867	4.90227000156656	913.7040533832395	-0.0405121674008342	0.8001	169	13	READ	PIK3CA	Approved in same tumor type	COPANLISIB | SORAFENIB | DASATINIB
983.1031608563952	6.72852283916831	979.2902843217544	-0.144221125331114	0.8614	202	19	LAML	IDH1	Approved in same tumor type	DASATINIB | ABT-199 | OLAPARIB
834.8126126836312	-12.1477213980058	820.9998745597055	0.000296651152098093	0.6895	599	77	GBM	EGFR	Approved in same tumor type	BOSUTINIB | SORAFENIB | REGORAFENIB
747.2397132801259	-1.58371211522243	761.0287123864437	-2.02645798122421	0.6198	512	15	UCEC	EGF	Approved in same tumor type	PONATINIB | DASATINIB | BOSUTINIB
765.0029365150931	-2.30860350038387	765.0000025646443	4.66932351628202e-06	0.6274	934	32	BRCA	MAP2K4	Approved in same tumor type	ARSENIC TRIOXIDE | VINBLASTINE | CC-401
781.290990212214	-15.2690561693587	782.9998123292199	-1.30335365611245e-05	0.6478	343	10	HNSC	RB1	Approved in same tumor type	DASATINIB | PONATINIB | BOSUTINIB
768.8581114627488	22.1583986402403	767.995173968145	8.72951571918247	0.6319	512	35	UCEC	TAF1	Approved in cancer	DOXORUBICIN | 943962-47-8 | GTPL9524
802.1248549032863	-5.54447785812783	786.3842992710217	-2.85467758625191	0.6539	543	25	LUAD	KDR	Approved in same tumor type	COPANLISIB | MIDOSTAURIN | BOSUTINIB
757.7356111865344	-10.7252070273926	765.5492846685341	1.79526013180521	0.6281	153	5	BLCA	CSF1R	Approved in cancer	COPANLISIB | DACTOLISIB | ALPELISIB
795.6242879769062	-0.179536184394266	787.2360542770091	1.34331007967717	0.6539	292	6	STAD	IRS1	Approved in same tumor type	COPANLISIB | EVEROLIMUS | TEMSIROLIMUS
1020.4322005775515	3.5313624525956	1014.524840447529	0.00515365328510597	0.9047	202	8	LAML	KIT	Approved in same tumor type	SUNITINIB | SORAFENIB | DASATINIB
955.5616514543153	3.1605482032771	956.9987903444247	0.000347423666653413	0.8414	502	18	KIRC	PTEN	Approved in cancer	BOSUTINIB | PONATINIB | DASATINIB
1052.3049594010768	-0.813736215714442	1055.9998089339826	7.35436642571585e-05	0.9515	292	11	STAD	SMAD4	Approved in cancer	NILOTINIB | DASATINIB | PALBOCICLIB
797.6593092250166	-5.1325862340303	797.753022799649	1.37814598683894	0.6637	512	15	UCEC	NLRP3	Approved in other pathologies and in clinical trials in cancer	VX-765 | EMRICASAN | LAX-101
761.4254850114008	-5.01953800917164	761.9999677555139	-8.14562040432065e-05	0.624	343	14	HNSC	RASA1	Approved in same tumor type	BOSUTINIB | TRAMETINIB | COBIMETINIB
770.9847770223444	-11.9545489489229	776.1488456486943	-0.308550269803618	0.6378	512	17	UCEC	LIFR	Approved in cancer	PEMETREXED | SERDEMETAN | PARTHENOLIDE
741.4612255585844	4.72372795471529	752.0000200978296	-1.79134722202434e-05	0.6135	153	4	BLCA	SCYL3	Clinical trials in cancer	NUTLIN-3 | CYTOCHALASIN B | TIPIFARNIB-P2
1058.6299469826838	3.65998945534594	1063.9998375749428	-0.000500760767408792	0.9603	153	14	BLCA	RB1	Approved in same tumor type	ARSENIC TRIOXIDE | DASATINIB | PALBOCICLIB
725.3763533139306	-1.99053024987805	735.609747451011	-1.10059912639917	0.6044	264	21	SKCM	FN1	Approved in cancer	BOSUTINIB | DASATINIB | PONATINIB
783.0753958880368	-8.04137062170796	781.362023917466	1.54964093977412	0.6457	389	11	LUSC	TIAM1	Clinical trials	QUERCETIN | GUANOSINE 5&#39;-DIPHOSPHATE | BISINDOLYLMALEIMIDE I
924.741198293514	-2.44488576387914	923.9998923758191	0.000261551842186236	0.8046	180	5	PRAD	TP53	Approved in same tumor type	PACLITAXEL | ABT-199 | BORTEZOMIB
798.4342920372255	20.0592715725907	790.8704874061971	10.9434572209339	0.6481	264	15	SKCM	MAP3K5	Approved in same tumor type	COBIMETINIB | PACLITAXEL | ABT-199
932.4229773079254	9.39873765867361	934.6237520072783	-3.2363100115731	0.8125	292	15	STAD	CREBBP	Approved in same tumor type	PONATINIB | REGORAFENIB | ARSENIC TRIOXIDE
916.8404551121895	74.8200254322831	920.0013601495655	-0.000549211453915177	0.8004	57	22	PAAD	TP53	Approved in same tumor type	ABT-199 | BORTEZOMIB | ERIBULIN
767.0518187358599	-7.77155800179031	776.094305607263	3.08770740868954	0.6372	512	12	UCEC	PSIP1	Approved in cancer	FQI1 | PARBENDAZOLE | ISOEVODIAMINE
765.3208233793562	-20.6069620768454	780.8164110761938	-19.6456977336384	0.6358	264	13	SKCM	PDGFRB	Approved in same tumor type	IMATINIB | SORAFENIB | PAZOPANIB
894.7201609258369	-1.5919624083958	892.6298354496934	-0.330199539114346	0.7671	343	7	HNSC	AR	Approved in cancer	ENZALUTAMIDE | BICALUTAMIDE | FLUOXYMESTERONE
898.7227390556197	-3.11952670808202	891.6906793753112	2.30636197461627	0.7689	343	9	HNSC	KCNQ3	Approved in other pathologies and in clinical trials in cancer	CELECOXIB | RETIGABINE | GUANIDINE HYDROCHLORIDE
770.5555866269223	-7.93949648929282	769.8917790954374	2.77848397614594	0.6355	512	18	UCEC	NUP98	Approved in other pathologies	INDISULAM | ZEBULARINE | FQI1
993.5537839347946	96.0702771892171	983.8868817644911	18.1256221029626	0.8614	222	131	LGG	IDH1	Approved in same tumor type	ABT-199 | OLAPARIB | GEMCITABINE
749.7931046106055	-4.05910380414983	763.6905718514299	0.261611107095405	0.6225	512	15	UCEC	DAPK1	Approved in cancer	PALBOCICLIB | RIBOCICLIB | ABEMACICLIB
763.7631342091846	11.1217667185416	772.1147378738995	-2.52146515976983	0.6358	292	9	STAD	PDGFRB	Approved in same tumor type	SORAFENIB | REGORAFENIB | DASATINIB
752.7187322429861	-2.3105796969308	752.9999687603703	0.000661222781900506	0.6149	169	4	READ	TRRAP	Approved in other pathologies	P-0850 | MANUMYCIN | ZEBULARINE
